Lab Consequence

This route answers the downstream question: if the repository recommends a follow-up, what real burden, control demand, refusal case, or observed-outcome feedback still keeps that recommendation honest.

bijux-proteomics-lab matters more now because the upstream product is stronger. More scientific and analytical depth creates more downstream pressure, not less. A stronger benchmark packet is only useful if the follow-up story remains executable, reviewable, and honest about cost.

What Consequence Means Here

The lab route is where the repository makes explicit:

• what is executable versus only advisory
• what control burden and readiness gates still apply
• what should be refused rather than optimistically handed off
• what was requested versus what was actually run
• how observed outcome should narrow or strengthen the next recommendation

This is why strong benchmark or runtime evidence can still end in a narrower public sentence.

What Is Stronger Than Before

• the lab package now owns real planning, readiness, handoff, refusal, and outcome-reconciliation surfaces across the flagship families
• downstream burden is visible enough now that recommendation language cannot quietly imply cheap or obvious follow-up
• requested-versus-observed outcome learning is part of the public chain instead of a hidden maintainer interpretation step

What This Route Should Settle

• whether a family still stops at exploratory-only follow-up
• whether the recommendation survives control demand and operator burden
• whether refusal is the most honest downstream action
• whether observed outcome should tighten or weaken the next public sentence

Family-Level Consequence Reading

family	consequence posture today	main downstream limiter
dda	bounded follow-up value	stronger execution review still does not erase follow-up cost and control demand
dia	bounded follow-up value	absent-peptide and downstream interpretation burden still narrow the call
lfq	exploratory follow-up only	cohort and normalization uncertainty still make stronger consequence language unsafe
ptm	exploratory follow-up only	localization confidence still outruns follow-up certainty
targeted	exploratory follow-up only	calibration, interference, and burden can still flip the recommendation
multiplex	internal support only	downstream trust still collapses under the current stress packet

Start Here

• Open Outcome Learning Loops when the question is how observed follow-up should tighten the next release sentence.
• Open Workflow Refusal Handbook when the honest next action may be to stop, narrow, or refuse.
• Open Decision Support when the disagreement still spans evidence, recommendation, and burden.
• Open Current Capability Limits when the question is whether current follow-up limits still block stronger repository wording.

What This Route Prevents

• treating a strong benchmark packet as if downstream validation were cheap
• treating assay feasibility as if it were the same thing as assay worth
• treating blocked or narrowed follow-up as if it had no effect on the next public sentence

Boundary

This route owns downstream consequence pressure. It should not start teaching package architecture before the reader knows whether the lab question is the real limiting factor.